Filtrer vos résultats
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
Efficacy of vedolizumab in perianal Crohn's disease: the BioLAP multi-centre observational study14. Congress of ECCO, European Crohn’s and Colitis Organisation, Mar 2019, Copenhague, Denmark. ⟨10.1093/ecco-jcc/jjy222.112⟩
Communication dans un congrès
hal-03552294v1
|
||
|
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradicationHepatology, 2018, 68 (4), pp.1245-1259. ⟨10.1002/hep.30034⟩
Article dans une revue
hal-02648452v1
|